An exceedingly rare case of de novo hepatic angiosarcoma in a transplanted liver

De novo primary hepatic angiosarcoma is an exceedingly rare malignancy in transplanted livers. Only 1 previous case has been reported in the literature. The diagnosis is usually challenging due to non-specific clinical presentation and overlapping imaging findings with other conditions. These rapidly progressing, multifocal lesions have previously been described to have varied growth patterns but are typically hypo-enhancing on gadoxetate disodium (Primovist) enhanced MRI. Surgical resection and adjuvant chemotherapy are potential options of treatment for hepatic angiosarcomas. Despite this, prognosis of patients at diagnosis is extremely poor. In this report we present imaging findings of a liver transplant recipient despite biopsy-confirmed hepatic angiosarcoma, and discuss the diagnostic complexities involved.

Authors

Institutions

Publication Details

Journal
Radiology Case Reports
Published
2025-10-11
DOI
https://doi.org/10.1016/j.radcr.2025.09.025
Primary Topic
Vascular Tumors and Angiosarcomas
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

An exceedingly rare case of de novo hepatic angiosarcoma in a transplanted liver

Howard Chow, Joshua Liu, Samer Ghattas, David M. Bowen
Radiology Case Reports
Vascular Tumors and Angiosarcomas
article

An exceedingly rare case of de novo hepatic angiosarcoma in a transplanted liver

Howard Chow, Joshua Liu, Samer Ghattas, David M. Bowen
article en

Abstract

De novo primary hepatic angiosarcoma is an exceedingly rare malignancy in transplanted livers. Only 1 previous case has been reported in the literature. The diagnosis is usually challenging due to non-specific clinical presentation and overlapping imaging findings with other conditions. These rapidly progressing, multifocal lesions have previously been described to have varied growth patterns but are typically hypo-enhancing on gadoxetate disodium (Primovist) enhanced MRI. Surgical resection and adjuvant chemotherapy are potential options of treatment for hepatic angiosarcomas. Despite this, prognosis of patients at diagnosis is extremely poor. In this report we present imaging findings of a liver transplant recipient despite biopsy-confirmed hepatic angiosarcoma, and discuss the diagnostic complexities involved.

Radiology Case ReportsVol. 21(1)
Royal Prince Alfred Hospital (AU)
Openalex Percentile: Top 61%
Vascular Tumors and Angiosarcomas
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

An exceedingly rare case of de novo hepatic angiosarcoma in a transplanted liver — Howard Chow, Joshua Liu, et al. · Radiology Case Reports (2025) | TGRS Research Map | TGRS